Therefore, the inhibition of PDE5 increases intracellular cGMP levels, producing vasodilatory and anti-remodeling effects, and having synergism with inhaled NO in the treatment of PH in newborns with CDH [16,17,18,19]. This evidence concerns the gene PDE5A and congenital diaphragmatic hernia.